These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5907368)

  • 21. MENOPAUSAL BLEEDING.
    BURT RK
    Appl Ther; 1964 Jun; 6():521-2. PubMed ID: 14167342
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of norethindrone on metropathic bleeding.
    Koetsavang A; Porapakkham S
    J Med Assoc Thai; 1972 Jul; 55(7):406-13. PubMed ID: 5052583
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequential mestranol and morethisterone in the treatment of the climacteric syndrome.
    Moore B
    Postgrad Med J; 1976; 52 Suppl 6():39-47. PubMed ID: 981118
    [No Abstract]   [Full Text] [Related]  

  • 24. Progestin-estrogen combinations in management of acne.
    Kostant GH
    J Med Soc N J; 1965 Nov; 62(11):523-6. PubMed ID: 4220687
    [No Abstract]   [Full Text] [Related]  

  • 25. NORETHINDRONE MESTRANOL AS A THERAPEUTIC AGENT.
    CAMERON WJ; WARREN JC
    Appl Ther; 1964 Jun; 6():511-8. PubMed ID: 14167339
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment effectiveness in dysfunctional uterine hemorrhages using the gestagen, Norcolut].
    Prilepskaia VN; Kulakov VI; Baklaenko NG; Laricheva IP
    Akush Ginekol (Mosk); 1979 Oct; (10):29-31. PubMed ID: 507332
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of Non-ovlon in female patients with acne vulgaris].
    Klinger G; Reich P; Hempel E
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1202-5. PubMed ID: 4251329
    [No Abstract]   [Full Text] [Related]  

  • 28. Influences of gestagen upon carcinoma in situ of the cervix (a histologic study).
    Yokoyama Y
    Acta Obstet Gynaecol Jpn; 1972 Jan; 19(1):33-9. PubMed ID: 4119434
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders].
    Fiorino S; Rossi T; Scio A
    Quad Clin Ostet Ginecol; 1966 May; 21(5):282-310. PubMed ID: 5988967
    [No Abstract]   [Full Text] [Related]  

  • 30. [Feedback--regulation mechanisms using a multiple graded mestranol-norethisterone sequential preparation in XO Turner's syndrome].
    Roll H; Breckwoldt M; Amann K
    Arch Gynecol; 1979 Jul; 228(1-4):575-6. PubMed ID: 485482
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and morphological parallels in the treatment of dysfunctional uterine hemorrhages with Infecundin].
    Tikhomirov BM
    Akush Ginekol (Mosk); 1972 Apr; 48(4):64-5. PubMed ID: 4639209
    [No Abstract]   [Full Text] [Related]  

  • 32. Catamenial pneumothorax. Bilateral occurrence while on suppressive therapy.
    Wilhelm JL; Scommegna A
    Obstet Gynecol; 1977 Aug; 50(2):227-31. PubMed ID: 876563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Emergency treatment of dysfunctional hemorrhage with ovulation inhibitors].
    Wespi HJ; Rehsteiner HP
    Geburtshilfe Frauenheilkd; 1966 Dec; 26(12):1576-84. PubMed ID: 5973352
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of acne in male patients with anovulatory compounds].
    Porto JA; Abreu J
    Hospital (Rio J); 1965 Jun; 67(6):1211-5. PubMed ID: 4221295
    [No Abstract]   [Full Text] [Related]  

  • 35. Dysmenorrhoea unrelieved by an oral contraceptive.
    Practitioner; 1968 Jun; 200(200):856-9. PubMed ID: 4871666
    [No Abstract]   [Full Text] [Related]  

  • 36. A small double-blind trial of an anovulant agent in acne vulgaris.
    Mackey JP
    Ir Med J; 1975 Apr; 68(8):203-4. PubMed ID: 124309
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary dysmenorrhea: combination vs sequential therapy.
    Buttram VC; Kaufman RH
    Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of abnormal bleeding.
    Cope E
    Br Med J; 1971 Jun; 2(5763):700-1. PubMed ID: 5556066
    [No Abstract]   [Full Text] [Related]  

  • 39. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease.
    Andersen RN; Givens JR; Wiser WL; Umstot ES
    Am J Obstet Gynecol; 1976 May; 125(2):166-9. PubMed ID: 944533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The synthetic estrogen-progestagens in therapy of menometrorrhagia of puberty].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1523-33. PubMed ID: 5744195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.